ArticleBreast cancer (Tokyo, Japan)2023

Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.

Leilei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.